• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于切割断层皮片移植的新型经皮应用麻醉制剂已进行测试。

New anaesthetic formulation for epicutaneous application tested for cutting split skin grafts.

作者信息

Ohlsén L, Englesson S

出版信息

Br J Anaesth. 1980 Apr;52(4):413-7. doi: 10.1093/bja/52.4.413.

DOI:10.1093/bja/52.4.413
PMID:6990949
Abstract

Ane-Pad (A 2358, Astra Lakemedel AB), a new local anesthetic formulation for application to the skin has been tested in the removal of split skin grafts. Ane-Pad is a thin cotton pad, containing a solution of 10% ketocaine base in a solvent mixture of isopropanol, glycerol and water. The pad has been used on the donor sites of 173 patients with a minimum application time of 1 h before surgery. Eighteen patients complained of slight, transient irritation immediately after application. After removal of the pad erythema was present in 39 patients and oedema in eight. In 157 patients (90.8%) analgesia was adequate. Two patients (1.1%) needed additional anaesthesia. The concentration of ketocaine in the blood was measured in 101 patients and did not exceed 850 ng ml--1. Therewere no systemic side-effects.

摘要

Ane-Pad(A 2358,阿斯特拉制药公司)是一种用于皮肤的新型局部麻醉制剂,已在取皮片移植手术中进行了测试。Ane-Pad是一种薄棉垫,含有10%酮卡因碱在异丙醇、甘油和水的混合溶剂中的溶液。该棉垫已用于173例患者的供皮区,术前最少使用时间为1小时。18例患者在使用后立即抱怨有轻微、短暂的刺激。取下棉垫后,39例患者出现红斑,8例出现水肿。157例患者(90.8%)镇痛效果良好。2例患者(1.1%)需要额外麻醉。对101例患者进行了血液中酮卡因浓度的测量,浓度不超过850 ng/ml-1。未出现全身性副作用。

相似文献

1
New anaesthetic formulation for epicutaneous application tested for cutting split skin grafts.用于切割断层皮片移植的新型经皮应用麻醉制剂已进行测试。
Br J Anaesth. 1980 Apr;52(4):413-7. doi: 10.1093/bja/52.4.413.
2
An anaesthetic lidocaine/prilocaine cream (EMLA) for epicutaneous application tested for cutting split skin grafts.一种用于经皮应用的麻醉利多卡因/丙胺卡因乳膏(复方利多卡因乳膏),用于测试切割分层皮片移植。
Scand J Plast Reconstr Surg. 1985;19(2):201-9. doi: 10.3109/02844318509072377.
3
Percutaneous anaesthesia for taking split skin grafts.取断层皮片时的经皮麻醉。
Scand J Plast Reconstr Surg. 1977;11(1):79-82. doi: 10.3109/02844317709025501.
4
Skin surface application of ketocaine to provide local anaesthesia for cutting split skin grafts.皮肤表面涂抹酮卡因以在切取分层皮片移植时提供局部麻醉。
Br J Plast Surg. 1977 Oct;30(4):251-4. doi: 10.1016/0007-1226(77)90110-2.
5
Percutaneous anaesthesia for dermabrasion.皮肤磨削术的经皮麻醉
Scand J Plast Reconstr Surg. 1978;12(3):287-90. doi: 10.3109/02844317809013007.
6
Percutaneous anaesthesia for some minor surgical procedures.用于一些小手术的经皮麻醉。
Scand J Plast Reconstr Surg. 1978;12(3):283-6. doi: 10.3109/02844317809013006.
7
Maternal and foetal drug levels after epicutaneous application of a local anaesthetic formulation containing ketocaine for possible use as pain relief in labour.用于分娩时可能作为止痛剂的含酮卡因局部麻醉制剂经皮应用后的母体和胎儿药物水平。
Acta Anaesthesiol Scand. 1981 Feb;25(1):73-5. doi: 10.1111/j.1399-6576.1981.tb01610.x.
8
Percutaneous analgesia with ASTRA 2358 for taking split-thickness skin grafts. A preliminary report.使用ASTRA 2358进行经皮镇痛以获取中厚皮片。初步报告。
Acta Anaesthesiol Scand Suppl. 1978;70:92-4.
9
Relief from pain localized to the lower back in early labour. A double blind trial of ketocaine, a new, highly effective, local, cutaneous analgesic (A 2358, Ane-Pad), and placebo.缓解分娩早期下背部局部疼痛。一项关于新型高效局部皮肤镇痛药酮卡因(A 2358,Ane-Pad)与安慰剂的双盲试验。
Z Geburtshilfe Perinatol. 1981 Dec;185(6):360-3.
10
Determination of ketocaine blood concentrations following brachial plexus block and epicutaneous administration.臂丛神经阻滞和经皮给药后酮卡因血药浓度的测定。
Acta Pharm Suec. 1977;14(5-6):425-34.

引用本文的文献

1
A risk-benefit assessment of topical percutaneous local anaesthetics in children.儿童局部经皮局部麻醉药的风险效益评估。
Drug Saf. 1997 Apr;16(4):279-87. doi: 10.2165/00002018-199716040-00005.
2
Setting up a drip.正在建立静脉滴注。
Br Med J. 1980 Jun 28;280(6231):1619. doi: 10.1136/bmj.280.6231.1619-a.